Thanks TT. So, in effect there are 2 pathways for reimbursement of medical devices in Germany.
(1) One pathway is for hospitals to apply for top up funding with the NUB following negotiations with Oncosil.
(2) The second pathway is to obtain GBA approval for national reimbursement following the trial by the hospitals approved by GBA.
My question therefore is how long will all this take for Oncosil to actually get the dollars (sorry Euros) thru the door either under Pathway 1 or Pathway 2?
Thanks TT. So, in effect there are 2 pathways for reimbursement...
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(10.0%) |
Mkt cap ! $16.66M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $1.872K | 390.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 26286683 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27925533 | 25 |
View Market Depth
| Last trade - 12.16pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 25.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 50000 | ||
| Last updated 12.34pm 22/05/2024 ? | |||||
| OSL (ASX) Chart |